microscopIA will provide structured training in:

• the research protocol;

• provider identification;

• source hierarchy;

• service classification;

• source documentation;

• facility verification;

• geolocation;

• geographic-information-system methodology;

• travel-time modeling;

• real-world model validation;

• database quality control;

• manuscript development;

• policy-brief preparation; and

• scientific communication.

Participants are nevertheless expected to self-manage routine project activities.

The participant team will jointly distribute:

• departments and municipalities;

• provider categories;

• facility-verification responsibilities;

• conflict-victim datasets;

• real-world travel-time validation routes;

• quality-control activities; and

• manuscript-development responsibilities.

The team must select one participant as Team Leader.

The Team Leader will:

• coordinate internal task distribution;

• monitor completion of assignments;

• consolidate progress information;

• identify unresolved provider or data-verification issues;

• coordinate internal deadlines;

• present periodic reports to the Principal Investigator; and

• facilitate completion of project milestones.

Technical considerations

Participants will identify and verify healthcare organizations capable of providing relevant components of the clinical pathway, including:

• orthopedic surgery;

• amputation surgery;

• trauma surgery;

• reconstructive surgery;

• prosthetic manufacturing;

• prosthetic fitting;

• prosthetic repair and maintenance;

• orthotic services;

• physical medicine and rehabilitation;

• physiotherapy;

• occupational therapy;

• prosthetic rehabilitation; and

• multidisciplinary amputee services.

For each eligible provider, participants should collect, when available:

• facility name;

• organization type;

• public/private/non-profit status;

• civilian or military status;

• address;

• municipality;

• department;

• geographic coordinates;

• orthopedic surgical capabilities;

• amputation-related surgical capabilities;

• prosthetic services;

• upper-limb prosthetic services;

• lower-limb prosthetic services;

• pediatric capability;

• manufacturing capability;

• fitting capability;

• rehabilitation capability;

• maintenance and repair capability;

• funding mechanisms accepted;

• website and contact information;

• source;

• verification date; and

• verification status.

Every provider must remain traceable to an official registry, institutional source, direct confirmation, or another verifiable source. The source protocol explicitly prohibits fabrication of facility numbers, coordinates, or service capabilities.

Real-world validation

A dedicated participant responsibility will be to collect data allowing external validation of the modeled travel-time estimates.

Participants will identify suitable origin-destination pairs connecting affected municipalities, healthcare facilities, or documented patient/referral routes.

For each validation route, participants should obtain the most reliable feasible reference travel-time information, which may include:

• prospectively documented travel times;

• provider-reported referral travel times;

• health-system or institutional transport records where available;

• documented patient or referral journeys;

• verified ambulance or medical-transport records where accessible;

• repeated route measurements using standardized routing procedures; or

• other independently documented real-world travel observations approved by the investigators.

For each observation, participants should document:

• origin;

• destination;

• date or reference period;

• transport modality;

• observed or reference travel time;

• route source;

• relevant road or geographic conditions;

• modeled travel time; and

• source and verification status.

These observations will be compared with model predictions to determine whether the geospatial model systematically underestimates or overestimates actual travel time.